SCHEMBL26124281

SCHEMBL26124281

O=C1OC(Br)c2cc(Br)cc(C(F)(F)F)c21

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26123978 0.83 KDM1A (0.33) KDM1A
SCHEMBL31204368 0.78 — —
SCHEMBL26123818 0.78 KDM1A (0.30) KDM1A
SCHEMBL11403388 0.78 CA1 (0.34) —
SCHEMBL26125656 0.75 NOTUM (0.31) —
SCHEMBL25151104 0.75 MAOA (0.35) —
SCHEMBL26122062 0.75 NMT1 (0.32) —
SCHEMBL26121941 0.74 EPHX2 (0.34) —
SCHEMBL30546380 0.66 KDM4E (0.36) KDM1A
SCHEMBL26121808 0.66 KDM4E (0.36) KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023192989-A2 PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS AZKARRA THERAPEUTICS, INC. (US) 2023-10-05 — — WO disclosed
WO-2023192989-A2 PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS AZKARRA THERAPEUTICS, INC. (US) 2023-10-05 — — WO disclosed
Send feedback